Cargando…
Targeting of EGFR by a combination of antibodies mediates unconventional EGFR trafficking and degradation
Antibody combinations targeting cell surface receptors are a new modality of cancer therapy. The trafficking and signalling mechanisms regulated by such therapeutics are not fully understood but could underlie differential tumour responses. We explored EGFR trafficking upon treatment with the antibo...
Autores principales: | Jones, Sylwia, King, Peter J., Antonescu, Costin N., Sugiyama, Michael G., Bhamra, Amandeep, Surinova, Silvia, Angelopoulos, Nicos, Kragh, Michael, Pedersen, Mikkel W., Hartley, John A., Futter, Clare E., Hochhauser, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970994/ https://www.ncbi.nlm.nih.gov/pubmed/31959764 http://dx.doi.org/10.1038/s41598-019-57153-9 |
Ejemplares similares
-
Stress-specific p38 MAPK activation is sufficient to drive EGFR endocytosis but not its nuclear translocation
por: Tomas, Alejandra, et al.
Publicado: (2017) -
WASH and Tsg101/ALIX-dependent diversion of stress-internalized EGFR from the canonical endocytic pathway
por: Tomas, Alejandra, et al.
Publicado: (2015) -
Confinement of unliganded EGFR by tetraspanin nanodomains gates EGFR ligand binding and signaling
por: Sugiyama, Michael G., et al.
Publicado: (2023) -
EGFR trafficking: effect of dimerization, dynamics, and mutation
por: Schultz, Destiny F., et al.
Publicado: (2023) -
Trafficking Unconventionally via UPS
por: Tang, Bor Luen
Publicado: (2020)